Skip to main content
. Author manuscript; available in PMC: 2018 Jul 6.
Published in final edited form as: Genet Med. 2018 Jan 4;20(9):1069–1076. doi: 10.1038/gim.2017.223

Table 2.

Understanding of Informed Consent

Survey Item (Correct Answer) % Correct
Study Purpose (What are the main reasons this project is being done?)
To study how genomic information is used in healthcare decisions (True) 99%
To test a new gene-targeting drug (False) 91%
To create a map of the human genome (False) 67%
Study Procedures (This study involves…)
 An experimental drug (False) 100%
 A blood draw (True) 100%
 At least 4 study visits (True) 97%
 Completing surveys (True) 97%
 Genetic testing of my family members (False) 95%
Randomization (What information will you receive as part of this study?)
I have a 50% chance of receiving info from my whole genome sequence (True) 98%
I will definitely receive information from my whole genome sequence (False) 94%
I have a 50% chance of receiving info about my family history (False) 70%
I will definitely receive information about my family history (True) 60%
Results Returned (As part of this study, I may receive results that include…)
My risk of developing certain diseases for which there are no known preventions, cures, or treatments available (True) 98%
Personal genetic traits, such as eye and hair color (False) 90%
New information that doctors or researchers do not understand (True) 81%
Study Procedures and Related Risks
My results will be placed in my medical record (True) 100%
My results will be discarded when I complete this study (False) 98%
Partners HealthCare System will pay for additional medical tests to follow up on my results (False) 93%
I’m protected by federal law from genetic discrimination by health insurers & employers (True) 92%
My results will not be accessible to anyone outside of Partners HealthCare System (False) 87%
My de-identified WGS results will be shared with other researchers in a national database over the Internet (True) 86%